GPR55 and glioblastoma: While GPR55 did not show a significant correlation with GBM prognosis in this study, our group is investigating its potential expression profile in patient samples and the possible molecular effects of cannabinoid treatments to clarify these inconsistencies and resolve discrepancies between the literature and various databases.